Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.
Reliable and reproducible methods for the measurements of artemisinin and its derivatives in body fluids have proved difficult to develop. The available evidence suggests that all compounds are hydrolysed to a biologically active metabolite, dihydroartemisinin, which is eliminated rapidly. The role...
Hoofdauteur: | White, N |
---|---|
Formaat: | Conference item |
Gepubliceerd in: |
1994
|
Gelijkaardige items
-
Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
door: Lohy Das, J, et al.
Gepubliceerd in: (2017) -
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
door: André Daher, et al.
Gepubliceerd in: (2019-09-01) -
Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
door: White, N, et al.
Gepubliceerd in: (1999) -
Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
door: White, N, et al.
Gepubliceerd in: (1999) -
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
door: Das, J, et al.
Gepubliceerd in: (2018)